Russian Chipmaker Baikal Goes Bankrupt, Assets Valued at Only $5 … – Tom's Hardware

(Image credit: Baikal Electronics) T-Platforms, the parent company of Russian chipmaker Baikal Electronics, has declared bankruptcy and is auctioning off its assets, including intellectual property related to Baikal processors, one of a few designers of CPUs and system-on-chips from Russia, reports CNews. According to Kommersant, the total value of these assets is estimated at $5 million.…

Cathro & Partners appoints Mark Cook as director – Consultancy.com.au

Boutique restructuring consultancy Cathro & Partners has appointed Mark Cook as a director. Founded in 2021 by industry expert Simon Cathro, Cathro & Partners specialises in restructuring, turnaround, personal and corporate insolvency, safe harbour, secured enforcement services, government advisory services and pre-lending services. The addition of Mark Cook bolsters the firms senior team, with Cook bringing…

Apellis announces corporate restructuring to drive growth of … – Ophthalmology Times

(Image Credit: AdobeStock/conceptcafe) Apellis Pharmaceuticals Inc announced a corporate restructuring to drive growth of pegcetacoplan injection (SYFOVRE) and pegcetacoplan (EMPAVELI), which the company said in a release would “position it for long-term success.” According to a company news release, the planned restructuring will include cost reduction initiatives that align with the companys near-term priorities and…

Turkish investors lose hope to revive metallurgy in Liepaja – Latvian … – Baltic Times

RIGA – Turkish-capital company Liepaja Steel has abandoned the plan to relaunch a metallurgical enterprise in Liepaja and will take the steel melting furnace it bought three years ago to Turkey, Latvian Television (LTV) reported on Monday. According to the LTV report, the company makes no secret of its disappointment over a failure to reach…

Apellis Pharmaceuticals : Costs Associated with Exit/Disposal – Form 8-K – Marketscreener.com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2023 Apellis Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-38276 27-1537290 (State or Other…

Apellis Announces Corporate Restructuring to Drive Growth of … – GlobeNewswire

Maximizing global leadership of SYFOVRE in geographic atrophy (GA) Streamlining the EMPAVELI business and prioritizing development of systemic pegcetacoplan in IC-MPGN/C3G Focusing research initiatives on retina and CNS Anticipated total cost savings of up to $300 million through 2024, which includes an approximately 25% reduction in current workforce and a reduction in external expenses WALTHAM,…

Corporate Insolvency Service Market See Huge Growth for New … – The Knox Student

Corporate Insolvency Service Market report focused on the comprehensive analysis of current and prospects of the Corporate Insolvency Service industry. This report is a consolidation of primary and secondary research, which provides market size, share, dynamics, and forecast for various segments and sub-segments considering the macro and micro environmental factors. An in-depth analysis of past…